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Abstract
Familial Dysautonomia (FD; Hereditary Sensory Autonomic Neuropathy; HSAN III) manifests from a failure in development of
the peripheral sensory and autonomic nervous systems. The disease results from a point mutation in the IKBKAP gene, which
encodes the IKAP protein, whose function is still unresolved in the developing nervous system. Since the neurons most
severely depleted in the disease derive from the neural crest, and in light of data identifying a role for IKAP in cell motility and
migration, it has been suggested that FD results from a disruption in neural crest migration. To determine the function of
IKAP during development of the nervous system, we (1) first determined the spatial-temporal pattern of IKAP expression in
the developing peripheral nervous system, from the onset of neural crest migration through the period of programmed cell
death in the dorsal root ganglia, and (2) using RNAi, reduced expression of IKBKAP mRNA in the neural crest lineage
throughout the process of dorsal root ganglia (DRG) development in chick embryos in ovo. Here we demonstrate that IKAP is
not expressed by neural crest cells and instead is expressed as neurons differentiate both in the CNS and PNS, thus the
devastation of the PNS in FD could not be due to disruptions in neural crest motility or migration. In addition, we show that
alterations in the levels of IKAP, through both gain and loss of function studies, perturbs neuronal polarity, neuronal
differentiation and survival. Thus IKAP plays pleiotropic roles in both the peripheral and central nervous systems.
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Introduction
Familial Dysautonomia (FD) is an autosomal recessive disease
whose hallmarks are decreased pain and temperature sensation, a
dysfunctional autonomic nervous system marked by cardiac
instability, vomiting crises, and renal failure [1]. The stage in
neuronal development in which the FD phenotype becomes
manifest is not known. An autopsy of a 2-year old FD patient, the
youngest age examined to date, showed massive neuronal death
including an 80% reduction in neuron number in dorsal root
ganglia (DRG) [2] and 90% in FD superior cervical ganglia [3].
Continued depletion of peripheral neurons continues throughout
life and results in the progressive degeneration of sensory and
sympathetic function.
Although 3 mutations in the IKBKAP gene have been identified,
the mutation in .99.5% of patients is in a splice acceptor site in
intron 20 and results in variable skipping of exon 20, a presumed
frameshift, and production of a mutant mRNA [4–6]. FD tissues
express both wild-type and mutant IKBKAP mRNA, although the
ratios vary depending upon the tissue type. Of several tissues
examined, the central and peripheral nervous systems express the
lowest levels of wild type IKBKAP mRNA and these are also the
tissues most negatively impacted in the disease [5,6].
The function(s) of the protein encoded by IKBKAP gene, which
is called IKAP and/or Elp1, is unresolved. Numerous studies
indicate that IKAP/Elp1 (from here on, referred to as IKAP) is a
subunit of the RNA Pol II Elongator complex [7–9]. In addition, a
current hypothesis is that IKAP plays a role in cell motility and/or
migration [reviewed in 10,11], with one study providing evidence
that it does so by organizing the actin cytoskeleton [12] and other
studies indicating a role for IKAP in microtubule organization
[13,14]. Genes downstream of IKAP identified in fibroblasts from
FD patients included many genes involved in cell motility [15].
Reductions in IKBKAP mRNA temporarily reduce the migration
of cortical neurons and the complexity of their dendritic structure
[16]. Given that the cell types that are depleted in FD derive from
the neural crest, a highly motile population that migrates to many
different target sites deep within the embryo, we sought to
investigate whether the IKAP protein is required in the neural
crest lineage for its proper migration and/or differentiation.
Neurons in the dorsal root ganglia and sympathetic ganglia
differentiate from neural crest cells (NCCs) that delaminate from the
trunk neural tube and migrate ventrally: those NCCs that stop next
to the dorsal aorta differentiate into the paravertebral chain of
sympathetic ganglia while those that stop dorsally, adjacent to the
neural tube, give rise to the chain of DRG [17–20]. For the PNS to
develop properly multiple key steps must occur: neural crest cells
must delaminate and migrate to their normal destinations, they must
differentiate into the correct cell type at those targets, they must then
undergo normal axonogenesis and extend axons that navigate
correctlytotheir required end organs, and a certainpercentagemust
then survive the normal period of programmed cell death.
Theoretically disruptions in any of these key events could cause FD.
To determine the steps that go awry to result in the FD
phenotype, it is first necessary to identity the stages of PNS
development in which IKAP is expressed; no such study has been
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migrating neural crest cells but instead only starts to be expressed
as neural precursors differentiate into neurons, both in the PNS
and CNS. Using shRNA, we reduced levels of IKBKAP mRNA in
ovo and found that alterations in IKBKAP levels affected the
genesis, differentiation, polarity and survival of neurons both in the
PNS and CNS.
Materials and Methods
Construction of shRNA-expressing plasmids
siRNA candidates for IKBKAP were identified using the
Whitehead Institute for Biomedical Reseach’s website (http://
jura.wi.mit.edu/bioc/siRNAext/show_oligo.cgi.). The predicted
chicken IKBKAP sequence (NCBI accession number AJ720452)
was entered into an analysis program and three siRNAs with
negative thermodynamic values were selected for the construction
of three hairpin vectors: sequence 59-AAGTCAGCTGATGTTC-
CTAGA-39 (IKP-4), sequence 59-AACCTTTATCAAGCAAA-
TAGA-39(IKP-7),andsequence59-AAGTGGCTAGACAGGCT-
TATG-39 (IKP-1). These sequences were subjected to BLAST
searches using GenBank’s nonredundant and EST databases to
ensure no off-target gene recognition. Oligonucleotides were
annealed and cloned into the pSilencer 1.0-U6 (Ambion, Austin,
TX:7208), predigested with ApaI and EcoRI restriction endonu-
cleases. The constructs obtained, psilencer IKP-4.5, psilencer IKP-
7.4, and psilencer IKP-1.6 each have their oligonucleotide inserts
cloned downstream of the mouse U6 promoter allowing the
expression ofthe shorthairpinRNAs.A hairpin plasmid ofthesame
length as the IKBKAP shRNA, 21 nucleotides, and similar % GC
content was used as a negative control shRNA. This sequence was
also subjected to Blast searches to ensure no gene recognition. To
create a second set of siRNA candidates targeted closer to the 59end
of the transcript, an algorithm developed by Maurice Ho at Hung
Kong University of Science and Technology, which is based on
Reynolds et al 2004 was used. Only the siRNA candidates with
scores of 7 or higher were screened for off target sequences as
described above, and 2 were selected to make hairpin vectors. One
targets the sequence 59-AGATCTACGTGTACAGATA-39 (IKP-
8) and the other targets 59-ACAGGCAGTTAATCAGATT-39
(IKP-3). Oligonucleotides were annealed and cloned into the
PBGFPH1 Vector (Gift from Dr. Xiaozhong Alec Wang,
Northwestern University). This vector allows for transposition into
the genome, giving long-term expression, and co-expression of
eGFP by a CMV promoter. The constructs obtained, PBIKP-8 and
PBIKP-3 each have their oligonucleotide inserts cloned down-
stream of the Human H1 promoter allowing the expression of the
short hairpin RNAs by RNA polymerase III. The IKP-7 and the
Control siRNA described above were also annealed into the
PBGFPH1 vector with the same methods.
CT-IKAP cloning
The C-terminal IKAP construct was generated by amplifying
cDNA made from Stage (St.) 28 chicken DRG mRNA and cloning
the product into pCS2-His. The C-terminal construct corresponds
to bp 3169–4069 in AJ720452. pCS2-His was cut with XhoI and
ClaI and then blunt ended with Vent polymerase and checked for
correct orientation.
Injection and electroporation of shRNAs in ovo
For shRNA mediated knockdown experiments, constructs were
injected/electroporated into the neural tubes of St.13/14 chick
embryos at a concentration of 0.5–2.5 ug/ul. To visualize
transfected cells in embryos transfected with IKBKAP shRNAs
7.4, 1.6 and 4.5, the EGFP expression vector pMES was included
in the mix at an 8-fold lower concentration. Two of the IKBKAPs
generated, 33 and 81 had EGFP encoded in the plasmid and did
not require co-injection of pMES; a separate control plasmid was
generated when using those 2 shRNAs. For rescue experiments,
IKBKAP 7.4 shRNA (1.5 ug/ul) was electroporated in combina-
tion with a construct encoding the full length mouse IKBKAP
subcloned into pMES (mIKBKAP pMES) at 0.25 ug/ul. As a
positive control, embryos were electroporated with mIKBKAP
pMES alone (0.25 ug/ul).
Immunostaining, generation of monoclonal antibodies
and in situ hybridization
Immunolabeling and tissue fixation and embedding were
carried out as previously described [21]. Fixed tissues were
cryosectioned at 16 um. The following antibodies were used: anti-
IKAP H302 (Santa Cruz), Tuj-1 (Covance), anti-His (Quiagen)
HNK-1, BEN, and Islet-1 (Developmental Hybridomas Bank),
anti-cleaved Caspase-3 (Cell Signaling), and all fluorophore-
conjugated secondary antibodies (Alexa Fluor 488 nm, 568 nm,
and 688 nm) were obtained from Invitrogen (Molecular Probes,
Eugene, OR). Monoclonal antibodies were generated against
amino acids 1–385 from the partial chicken IKAP sequence
(Accession number XP_423369) which corresponds to amino acids
852–1152 in the human IKAP sequence using standard
techniques. This region was amplified by PCR and ligated into
the pET46 EK/LIC vector. Expressed protein had a 66His tag
and was purified over a Ni column, followed by HPLC. Mice were
immunized and monoclonal antibodies generated and screened
according to standard techniques (Dr. Elizabeth A. Wayner, Fred
Hutchison Cancer Center, Seattle, WA). Monoclonal P1D8 was
used for these studies as it gave the strongest signal for
immunostaining and western blots. In situ hybridization were
conducted according to the same protocol as described in [21].
The probe was made by amplifying the region spanning from
nucleotide 3001–3730 in the chick IKBKAP mRNA (Accession
number AJ720452) using cDNA from chick E8.5 spinal cord
mRNA as a template according to [22]. The PCR-amplified
region was then cloned into pCR2.
RNA extraction and real-time quantitative PCR
Chick embryos (St. 14) were injected/electroporated in the
neural tube with shRNAs IKBKAP 1.6+4.5, (target gene; 2.5 ug/
ml) or of control shRNA construct (2.5 ug/ml). Embryos were
harvested at St. 19–20. A second group of chick embryos (St. 17–
18) were injected with 1 ug/ul of either PBIKP 71(target gene),
PBIKP 33 (target gene) or PBIKP03 (control). Embryos were
harvested at St. 19–20. In all cases, four embryos per construct
were harvested. Only electroporated and GFP positive tissues were
collected on ice. Tissue was washed twice with RNase free IX PBS
and pellets were frozen in liquid nitrogen. RNA was extracted
using Trizol, followed by one chloroform extraction and
isopropanol precipitation. cDNA was synthesized from RNA
(250 ng) using SuperScript III (Invitrogen) according to the
manufacturer’s instructions. Comparative real–time qRT-PCR
[23] was performed in 100-ul tubes using a Rotor gene 6000
(Corbett Research) thermal cycler. PCR was performed using the
Rotor –Gene SYBR Green PCR kit (Qiagen). Each cycle consisted
of denaturation for 10 seconds at 95 C, annealing for 20 seconds
at 58 C, and extension for 25 seconds at 72 C. Primer sequences
were as follow: B-actin left: 59-TGCGCATAAAACAAGACGAG;
B-actin right: 59-GACTGCTGCTGACACCTTCA; IKAP 4 left:
59-GAGAAGCAAATCCACCAGGA; IKAP 4 right: 59-CCTGT-
TTTCCCTCTGATCCA. The amplification efficiencies were
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by Corbett Research for the rotorgene. The relative quantification
ratio was determined using the efficiency corrected calculation
model, based on multiple samples [23]. B-actin had a coefficient of
variation of 5.2% under all conditions.
Cell culture
Dorsal root ganglia were dissected from Embryonic day 5–9.5
chick embryos (E5–9.5) and dissociated by incubation in 0.25%
trypsin-EDTA (Gibco) for 7 min at 37 C followed by trituration
through fire–pulled glass pipettes. The culture media consisted of
Neurobasal medium (Invitrogen) supplemented with B27 (1X,In-
vitrogen), Glutamax (1X,Invitrogen), Hybrimax Antibiotic\Anti-
micotic (1:100, Sigma), NGF (10 ng/ml, gift from Dr. Thomas
Large). Cells were plated on 8-well Nunc glass chamber slides that
were coated with poly-D-lysine (1:100, Sigma) and laminin 20 ug/
ml (Gibco). Approximately equal numbers of cells (52,500) were
plated per well. Immediately after plating, cells were transfected
with IKBKAP-7.4 shRNA or control shRNA via pn-Fect
(Neuromics, PN3375). Several ratios of pnfect:DNA were tested
with the optimum obtained 1.84:1. The cells were then cultured
for approximately 29 h at 37 C, 5.5% C02. After incubation
culture cells were fixed and inmunostained as previously described
[24]. To determine whether IKBKAP shRNAs altered cell
proliferation and/or neuronal differentiation in dissociated DRG
cultures, Brdu was added to the cultures and the cells were fixed
24 hrs later (as described in [24]). The number of GFP+/BrdU+
or GFP+/Tuj-1+ cells were quantified for each experiment, and a
ratio comparing control vs. IKBKAP shRNAs for each experiment
determined. For the BrdU+ experiment, a total of 556 GFP+/
control shRNA transfected cells were counted and 357 GFP+/
IKBKAP shRNA transfected cells in 3 separate experiment. For
determining neuronal differentiation, a total of 2866 GFP+/
control shRNA transfected cells and 2913 IKBKAP shRNA
transfected cells were counted, over 3 separate experiments.
Quantification
Determination of number of H3+ cells in ventricular
zone. Embryos were transfected at St. 13 and fixed at St. 23.
Embryos were then cryosectioned and immunolabeled with anti-
phosphoH3 antibodies and the number of H3+ cells determined at
the ventricular zone on both the transfected and non-transfected
sides of the spinal cords for 3 embryos in each condition: Control
shRNA, IKBKAP shRNA, or IKPBKAP shRNA+mouse IKBKAP
(Origene).
Determination of number of DRG neurons in shRNA-
transfected embryos. Embryos were injected/electroporated at
St. 13 and fixed at St. 24/25. Three shRNA-transfected embryos
were analyzed for each of two different IKBKAP shRNAs and the
control shRNA. Slides were labeled with Tuj1 or Ben, two neural
markers, and the percentage of GFP+/Tuj-1+ or GFP+/Ben+ cells
determined in DRG sections from each embryo.
Determination of number of cleaved Caspase 3+
cells. Embryos were injected/electroporated as above,
incubated until St. 25, fixed, sectioned and immunolabeled with
anantibodytocleavedcaspase3.Thenumberofcleaved caspase3+
cells in the DRG of embryos was determined on both the
transfected and non-transfected sides of the embryos and a ratio
generated to insure that cell death was a direct result of the shRNAs
and not due to potential non-specific effects of electroporation. The
number of cleaved-caspase 3+ cells was also determined in the
transfected half of the spinal cords in IKBKAP shRNA (n=3
embryos; 59 sections) and control shRNA transfected embryos
(n=2 embryos; 46 sections).
Determination of fate of CT-IKAP-His-tagged cells in the
PNS. Embryos were transfected with the CT-IKAP-His pCS2
or a control pCS2 plasmid encoding His and a myc tag at St. 13
and fixed at St. 21. Embryos were then cryosectioned and stained
with HNK-1 and/or Tuj-1 antibodies to identify the cell types and
with anti-His or anti-Myc tags to identify transfected cells.
Branching of ventral root fibers. Chicken embryos St. 11–
14 (average 13/14) were electroporated with IKBKAP shRNAs or
control shRNA. Electroporated embryos were harvested at St. 23–
26,fixedin4%PFAfor1–2 hrs,cryosectioned and immunolabeled.
The number of GFP+ branches emerging from the ventral root or
floor plate from the electroporated side of the spinal cord, were
quantified. A branch was considered a fiber that deviated from the
fascicle of axons emerging laterally from the ventral root, or as
individual fibers protruding ventrally from the floor plate. Branches
emanating from below the notochord were not included in the
analysis.
Statistics. Statistical significance for each data set (with the
exception of the number of pH3+ cells in Figure 4) was determined
by unpaired Student’s t-test. Statistical significance for the pH3+
data set was determined by ANOVA.
Results
IKBKAP expression begins as neural precursors
differentiate
FD devastates the sensory neurons in the dorsal root ganglia and
yet no careful temporal examination of IKBKAP expression in the
developing DRG or PNS has been conducted. We analyzed both
protein and mRNA expression for IKAP/IKBKAP during the
period of neural crest migration and DRG formation and
differentiation: St. 15/Embryonic Day (E) 2.5 – E9 (Figure 1).
In the trunk, the neural crest delaminate from the neural tube over
a period of 24 hrs from ca Hamburger and Hamilton (HH) St. 12
to HH St. 20 [18,19,25,26]. DRG development then proceeds
over the next few days with the onset of programmed cell death
beginning around E4.5 and lasting until ca E12 [27,28].
Importantly, all reagents tested failed to detect any IKAP
protein or mRNA in migrating neural crest cells (Fig. 1A–C).
Instead, in both the spinal cord and DRG anlagen, IKAP protein
and mRNA were first expressed in nascent neurons, beginning at
St. 17 (Fig. 1A–C, E, arrows). IKAP expression increases as
sensory neurons mature in the DRG (Fig. 1G, H, and I) and is
expressed during the period of programmed cell death (Fig. 1 G–I,
K). These results are consistent with the demonstration of IKBKAP
mRNA expression in the E21 rat DRG [29] and with expression
we and others have observed in the embryonic mouse DRG [30;
Lefcort and George, data not shown]. In addition, our data
demonstrate pronounced expression of IKAP/IKBKAP in the
developing spinal cord, particularly in the ventral horn motor
columns (Fig. 1G, H, J, K solid arrow head) and their axons
(Fig. 1F, arrow), in interneurons along the lateral margins of the
cord (Fig. 1C, E, arrowhead, F)and in the ventricular zone (VZ,
Fig. 1D,J arrowhead outline). The expression in the ventricular
zone is coincident temporally with mitogenesis that occurs here.
The protein and mRNA expression patterns complemented each
other well, with the major difference being the absence of
IKBKAP mRNA in axons. At higher magnification it was
apparent that the IKAP protein was strongly cytoplasmic,
primarily perinuclear with strong aggregation at the axon hillock
region wherein the Golgi apparatus resides (Fig. 1 E, I, arrows)
and robustly expressed within both central and peripheral axons.
IKAP is also strongly expressed in the pre-ganglionic Column of
Terni neurons (Figure 1H, arrow), which are the pre-ganglionic
IKAP/Elp1 Function in the Nervous System
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chain of ganglia.
Since this immunostaining series was conducted with a
commercial anti-Human IKAP antibody (Santa Cruz H302), we
generated monoclonal antibodies to chicken IKAP and tested
whether they confirmed the expression pattern obtained with the
commercial antibody, which they did (Figure 2). Preabsorption
with the immunogen used to generate the anti-chick IKAP
antibody blocked the immunolabeling (compare Figure 2B to 2C).
Both antibodies (P1D8 and H302) strongly label axons, and the
perinuclear and axon hillock regions of DRG neurons in vivo and
cultured in vitro (Fig. 2D,E). At this level of resolution it is difficult
to exclude that there may be some nuclear expression of IKAP,
but certainly the majority of IKAP protein is localized in the
cytoplasm. Western blots on lysates made from chick E9 spinal
cord (Figure 2F) show that both antibodies react with a band of
approximately 140 kDa. This is slightly smaller than the human
and mouse IKAP (150 kDa), however, no full length cDNA
encoding the chicken IKAP has yet been described so the
molecular weight for chicken IKAP is currently unknown.
To summarize, IKAP expression in the PNS begins at St. 17 as
neural precursor cells differentiate into neurons; it is not expressed
in neural crest cells. IKAP also commences expression in the spinal
cord as motor neurons and interneurons differentiate. In addition,
IKAP is expressed on the apical surfaces of neuroepithelial cells in
the ventricular zone.
Todeterminethe functionofIKBKAPinthedeveloping DRG,we
generated shRNAs to 5 regions of the chicken IKBKAP gene
(Figure 3A) and two control shRNAs (Methods) and transfected
these constructs into the developing neural tube in ovo. We injected/
electroporated shRNAs beginning at St. 12, prior to neural crest
emigration and incubated embryos for 1–4 days. All 5 shRNA
constructs generated very comparable results and were used
interchangeably throughout the studies. Evidence of the ability of
the shRNAs to reduce IKBKAP mRNA expression is demonstrated
in Fig. 3B–D and to reduce IKAP protein expression in Figure 3 E–
Figure 1. IKAP is expressed in PNS and CNS neurons, but not in neural crest cells. Chick embryo sections were immunolabeled with
commercial anti-IKAP antibody (Santa Cruz H302; red, A–I and with either HNK-1 (A; to label neural crest cells, green) or Tuj-1 (to label neurons; B).
IKAP protein (red, A–I) is not expressed in HNK+ neural crest cells (green, A), but is expressed in nascent neurons in the DRG anlagen (A–C, E, arrow)
and neural tube (B–C, E; arrowhead), and its expression is maintained through the period of programmed cell death (G–I). IKAP is also expressed in
progenitor cells in the ventricular zone (D,J open arrowheads) and in motor neurons (arrowhead) and axons (arrow) (F–H,J,K). IKAP is also strongly
expressed on the pre-ganglionic Column of Terni cells (arrow, H). In situ hybridization for IKBKAP confirms the protein expression pattern (J,K).
doi:10.1371/journal.pone.0032050.g001
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electroporated/transfected sides (right) of the spinal cord.
IKBKAP is required for normal CNS development
Although our study was aimed at investigating the function of
IKBKAP in the PNS, in order to transfect the neural crest, the
neural tube lumen is injected/electroporated before neural crest
delamination, along its anterior/posterior axis thereby transfecting
the neural tube unilaterally. Given that we had detected robust
expression of IKBKAP mRNA in the neural tube, we asked
whether reductions in IKBKAP mRNA might also perturb spinal
cord development. Recent studies show that reductions in IKBKAP
mRNA in cortical neuroblasts delayed their migration [16] and
that gene expression is altered in oligodendrocytes in the cerebrum
of FD patients [31]. In addition, CNS deficits such as seizures,
abnormal EEGs, poor motor coordination and altered brainstem
function have been reported in FD patients [32–35].
The transfected halves of IKBKAP shRNA-spinal cords were
typically narrower than the non-transfected side (Fig. 3 E,F). This
may be due to either an increase in cell death in IKBKAP shRNA-
transfected cells and/or a decrease in the number of mitotically-
active progenitors. We quantified the number of cleaved-caspase
3+ cells in the spinal cord and found while control shRNA
transfected spinal cord halves contained 0.9+1.43 cleaved cas-
pase3+ cells, IKBKAP shRNA-transfected spinal cord halves had
4.4+1.59 cleaved caspase3+ cells, a 4-fold increase in cell death
(p=0.000; Fig. 4A–D). To investigate changes in mitotic activity of
progenitors at the ventricular zone, we quantified the number of
phosphorylated histone H3+ progenitors (Fig. 4E–H). We found
that reductions in IKAP reduced the number of cycling
progenitors, an effect that was rescued by co-transfection in ovo
with a plasmid encoding full length mouse IKBKAP. Another
common effect of IKAP reduction was evagination of transfected
ventricular zone cells into the neural tube lumen (Figure 5B–D):
interestingly, these evaginated transfected cells expressed neural
markers such as Ben (Fig. 5B, C) and islet 1/2 (Figure 5D).
Reductions in IKBKAP mRNA also manifested in a reduction in
various spinal cord interneuron populations including the En-
grailed and dorsal islet1+ interneuron subpopulations (Fig. 5 E,F,I).
Lastly, reductions in IKAP caused aberrant branching from
spinal motor axons in the ventral root (arrow, Figure 5 G,H). We
measured approximately a 2-fold increase in the number of
branches extending from IKBKAP shRNA-transfected motor
axons in the ventral root (mean number of branches=0.41+0.056
SEM, n=161 sections counted; p=0.002) than in control-
shRNA-transfected motor axons (mean number of branch-
es=0.19+0.042 SEM, n=116 sections counted). Thus IKBKAP
is required for normal genesis and differentiation of CNS neurons.
IKBKAP regulates neuronal differentiation and survival in
dorsal root ganglia
Control and IKBKAP-shRNA-transfected neural crest cells
migrated normally and stopped appropriately in the incipient
DRG or sympathetic ganglion. We determined the fate of shRNA-
transfected cells in the DRG at E4.5/HHSt. 25. At this age, the
DRG is considered ‘‘immature’’ in that 30% of its cells are
mitotically-active progenitors and neural differentiation is just
getting underway [36]. While in control shRNA transfected
DRG, GFP+ cells were distributed throughout the ganglion and
morphologically appeared as both neurons and non-neurons
(Figure 6A), IKBKAP shRNA-transfected cells were sparse in
number and tended to have the morphology of mature differenti-
ated neurons (Figure 6B). Quantification of GFP+/Tuj-1+ cells
supported this observation and demonstrated that silencing of
IKBKAP with any of the 3 different shRNA constructs tested,
promoted premature neuronal differentiation of transfected pre-
cursor cells in the DRG (Figure 6C). We next asked whether there
was a bias in terms of the type of sensory neuron the IKBKAP
shRNA transfected cells differentiated into, i.e. TrkA, B or C+ cells,
since they correspond to distinct functional modalities. The
distribution of Trk expression was comparable to the normal
distributionofTrk co-expression at that age,withroughlyhalf ofthe
neurons being TrkC+, one third TrkB+ and one third TrkA+ (data
not shown; e.g. see 21 for description of Trk co-expression patterns).
We were struck by the sparse number of transfected cells present
in the DRG and tested whether enhanced cell death might occur
in IKBKAP shRNA transfected DRG. The normal period of
programmed cell death in the DRG begins at E4.5 [27], but the
numbers are quite low initially and gradually increase until E12.
While transfection with control shRNA did not cause an increase
in cell death in the DRG, transfection with each of three different
IKBKAP shRNAs led to a significant increase in the number of
Figure 2. Confirmation of IKAP expression with an anti-chick IKAP antibody. (A) Generation of a monoclonal antibody to chicken IKAP,
P1D8, confirms the expression pattern obtained with anti-human IKAP commercial antibody (H302). Both antibodies demonstrate that the majority of
IKAP is in the cytoplasm, primarily perinuclear, and in axons (A, C–E) both in vivo (A, C) and in DRG in vitro (D,E). Incubation with the peptide
immunogen used to generate P1D8 completely blocks labeling (compare B to C). Both IKAP antibodies label a band of approximately 140 kDa in
lysates of chick embryo spinal cord (F).
doi:10.1371/journal.pone.0032050.g002
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major hallmark of FD is a 90% reduction in neuronal numbers in
the DRG, our data suggest that the deficit could be due to both a
decrease in the absolute number of neurons initially generated in
the DRG due to premature depletion of the precursor pool, in
addition to their enhanced and premature death.
Ectopic expression of the IKAP C-terminus disrupts
sensory neurogenesis
The c-terminus of IKAP contains TPR-like motifs which are
found in proteins that mediate mitosis and neurogenesis [37]. The
IKAP c-terminus has been shown to bind JNK and is sufficient for
JNK activation [38]. Given that it is the c-terminal half of IKAP
which would be absent in FD cells should any truncated protein be
made, we sought to investigate its function in the developing
DRG. Embryo neural tubes were electroporated in ovo with a
construct encoding the c-terminus of chicken IKAP (CT-IKAP-
His; see schematic in Figure 3A) and incubated for 24 hrs. CT-
IKAP transfected neural crest cells delaminated and migrated,
however a significantly lower percentage than control-transfected
neural crest cells colonized the DRG proper and instead were
located laterally or dorsally to the DRG (Fig. 6 I, K–N). Of the few
cells that did coalesce with cells within the DRG, a significantly
lower percentage than control-transfected cells differentiated into
neurons (Fig. 6 J, M,N).
A role for IKAP in neuronal polarity, branching and
cytoskeleton organization
Reductions in IKBKAP mRNA have been shown to decrease
expression of several genes involved in cell motility and exocytosis,
to disrupt microtubule organization and decrease branching of
cortical neurons [12,13,15,16]. We therefore examined whether
IKBKAP reductions altered the morphology, polarity and/or
cytoskeleton of neurons in the DRG.
Since we could not transfect mature DRG neurons in ovo
directly, we instead dissected DRG from E5–E6 embryos and
transfected dissociated DRG cells in vitro and cultured cells for
24 hrs. At this age about 30% of the cells in the DRG are cycling
neural precursors [24,39]. We first quantified neuronal numbers
(Tuj1+/GFP+) to determine whether increased neuronal numbers
were also generated from transfected cells in vitro as they were in
ovo. There was a 70% increase in neurons in wells transfected with
IKBKAP shRNAs vs. control shRNA - transfected wells (Fig. 7A–
F; n=3 experiments; p=0.001) consistent with our findings in ovo.
We also measured potential effects of the IKBKAP shRNAs on cell
proliferation in vitro by including a pulse of BrdU and found a 40%
decrease in the number of transfected BrdU+/IKBKAP shRNA
transfected cells compared to control shRNA transfected cells
(n=3 experiments; p=0.022). This result supports our in ovo
finding that reductions in IKAP led to premature differentiation of
neural precursors.
Figure 3. IKBKAPshRNAs reducelevels of IKAPprotein and IKBKAP mRNA in ovo. (A) Schematic combines the known partial chicken IKBKAP
sequence with the human IKBKAP sequence and indicates the regions of chicken IKBKAP to which shRNAs were designed and the regions used as the
immunogens for generation of both antibodies (P1D8 and Santa Cruz H301). The cytoplasmic terminus of the chicken IKAP was used for the CT-IKAP
His construct overexpression experiments. QPCR indicated that approximately 50% of the IKBKAP mRNA was reduced following a 24 hr transfection in
ovo with the IKBKAP shRNAs, when compared to control levels of IKBKAP (B). In situ hybridization following IKBKAP shRNAs transfection in ovo also
showed reduced levels of IKBKAP mRNA (C) in the transfected half of the spinal cord (arrow); sense probe (D). Transfection in ovo with IKBKAP shRNAs
reduced levels of IKAP protein (E–H) on the transfected side only (compare the control half to the EGFP+ half of the spinal cord).
doi:10.1371/journal.pone.0032050.g003
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it promoted a significant increase in branching from the cell body
(Fig. 7 G,H), and increased the generation of two conjoined
neurons, which stayed interconnected to various degrees, via a
cytoplasmic bridge and/or by incomplete cytokinesis (Fig. 7 I,J), or
directly juxtaposed [Fig. 7K] or extensively interconnected via
filopodia. There were significantly more pairs of such conjoined
neuronal cells in the IKBKAP-shRNA transfected cultures than in
control shRNA transfected wells (Fig. 7L). Given that the
percentage of neurons was low in each culture (approximately
10%) and hence each individual neuron was easily detectable and
at low density, and the fact that the conjoined cells typically had
mirror symmetric morphologies, these conjoined neurons are most
likely sister cells and daughters of a shared transfected mother-
precursor cell. Tightly juxtaposed (Fig. 7M) or interconnected
(Fig. 7N) DRG neuronal cells were also commonly observed in ovo
in IKBKAP shRNA transfected embryos. These conjoined neurons
were frequently heavily interconnected, if not through filopodial
branches, than directly at the junction of the two cells as if
cytokinesis was incomplete. These data point to an effect of
IKBKAP on the cytoskeleton and suggests that it is required for the
normal transition from cell cycle completion to the differentiation
of daughter cells.
Discussion
It is well established that the clinical manifestations of FD result
from a depletion of neurons in the PNS, yet the steps that go awry
to produce this deficit have not been determined. The data
presented here are the first in vivo studies that identify the stages of
PNS development that require IKAP/Elp1. For example, the FD
neuronal deficit in the dorsal root ganglia could result from
problems with neural crest cell induction, delamination, migration,
and/or differentiation. Our study indicates that neural crest cells
are induced, delaminate and migrate normally when transfected
with IKBKAP shRNAs. This finding is supported by the fact that
IKAP is not expressed in neural crest cells; thus the postulate that
FD results from disruptions in neural crest motility and/or
migration are not supported by investigation of IKAP’s function
and expression in vivo reported here. Similarly, our data
demonstrate that the disease phenotype does not result from a
failure in neuronal differentiation, since peripheral neurons
differentiate from IKBKAP-shRNA-transfected neural precursors.
Rather, our data provide evidence that the deficit in neuronal
numbers that marks FD may result from two causes: (1])
peripheral precursor cells precociously differentiating into neurons
and (2) neurons prematurely dying. These findings may shed
insight on the pathological basis for the FD phenotype.
Using RNAi to investigate the mechanisms underlying the PNS
phenotype in FD is an appropriate and useful strategy given the fact
that FD tissues express varying levels of both wild type IKBKAP
mRNA and truncated mRNA [6] and hence FD cells are not truly
‘‘null’’ for IKAP protein. Thus our in vivo model is more analogous
to the humandiseasethan a knock-out mouse model would be,even
a conditional knock-out. This is further supported by the fact that
the IKBKAP knock-out mouse is embryonic lethal, dying by E9
[30,40; Lefcort and Tessarollo, unpublished].
A major finding reported here is that neurons expressing
reduced levels of IKAP died prematurely in the DRG; the
mechanisms mediating that death need to be elucidated. IKAP-
depletion has been shown to increase levels of pro-apoptotic genes
such as Bax in colon cancer-derived cells and to alter levels of a
number of pro-apoptotic genes in FD stem cells [41,42] and may
explain the developmental delay and early death observed in
IKAP null mice [40]. Yeast two hybrid studies have identified
binding of IKAP/Elp1 to BAT-3, an apoptosis regulatory gene
[43]. Our finding of premature differentiation of precursors
followed by precocious death is reminiscent of the premature
differentiation and subsequent death of DRG neuronal precursors
in the neurotrophin-3 (NT-3) knock out mouse [44].
Figure 4. Reductions in IKAP decreases proliferation of
progenitors and increases cell death in the developing neural
tube. Embryos were transfected/electroporated with IKBKAP shRNAs
(A,B) or control shRNAs (C,D) at St. 13 and fixed at St. 23 (ca 48 hrs).
Reductions in IKAP increase the death of CNS progenitors as indicated
by cleaved-caspase 3+ (A–D; vertical line indicates the midline). (E–H)
The number of pH3+ cells was determined in the ventricular zone on
the transfected and control sides of each embryo and a ratio for each
embryo obtained. The graph depicts those ratios from embryos
transfected with either control shRNA or IKBKAP shRNA or IKBKAP
shRNA and a mouse IKBKAP cDNA. There are significantly fewer pH3+
cells in IKBKAP shRNA transfected embryos (n=4 embryos, 3300 cells
counted) than in control shRNA transfected embryos (n=3 embryos,
4,331 cells counted; p=0.004), an effect that is rescued (red bar) with
co-transfection with a plasmid encoding full length mouse IKBKAP (E;
n=3 embryos, 2153 cells counted; p=0.005 by ANOVA). There is no
significant difference between the number of pH3+ cells in the rescued
embryos vs. the control shRNA transfected embryos (p=0.103).
doi:10.1371/journal.pone.0032050.g004
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neural precursor proliferation and preventing their precocious
differentiation into neurons. Decreasing IKBKAP mRNA levels
both in vivo and in vitro led to an increase in neuronal
differentiation, yet IKAP levels only become detectable as neural
precursors differentiate. Furthermore, overexpressing the cyto-
domain of IKAP reduced neuronal differentiation. Without more
structure/function studies we can not distinguish whether the
ectopically expressed truncated c-terminal IKAP protein acted as a
dominant negative or as a gain of function. Johansen et al [2008]
showed that overexpression of the N-terminal half of IKAP, either
in the presence or absence of the endogenous full length IKAP
caused a defect in cerebellar neuronal migration in vitro. Holmberg
et al [2002] showed that overexpression of the c-terminal half of
IKAP was sufficient to cause activation of the critical signaling
enzyme, JNK. Interestingly, Johansen et al also showed that in
IKAP-depleted cells in vitro, ectopic expression of the N-terminal
half of IKAP could not rescue the effects of IKAP depletion.
Furthermore, in the IKAP null mouse, Chen et al. [2009] found
that overexpression of the N-terminal half of IKAP could not
rescue the grave early embryonic lethality induced by total loss of
IKAP in mouse.nor could generation of a mouse in which only
exon 20 was deleted [40]. These last experiments indicate that key
functions for IKAP must reside in its C-terminal half, hence the
rationale for our experiment. Furthermore, these data would
suggest that the level of IKAP is critical and that small alterations
in the amount of IKAP in a PNS precursor cell can shift the
behavior of that cell between proliferation vs. differentiation.
Unfortunately there are no robust markers of chick DRG
precursor cells, but our data would suggest that IKAP must begin
to be expressed as cells exit the cell cycle and acts as a ‘‘break’’ to
prevent precocious differentiation. Decreases in Elp1 in Arabidopsis
thaliana has been shown to cause a decrease in proliferation [45],
and FD cells have been demonstrated to be in cell cycle arrest, an
effect released by phophatidylserine [46]. IKAP-dependent genes
include such cell cycle mediators as p57kip and thymidilate
synthetase [15]. Since the cytoskeleton and cell polarity proteins
are so integral to both cell division and cell motility, its not
surprising, given the accruing evidence for a role for IKAP in cell
polarity, that we found alterations in cell proliferation and cell
polarity with disruptions in IKBKAP. As published in previous
studies, we too found fewer paxilin-positive focal adhesions with
IKAP reduction [12] (data not shown). Since paxillin has been
shown to mediate the localization of both Crk and syntaxin-2 in
Figure 5. Reductions in IKAP alter neural tube development and induce ectopic branching of motor axons. All transfected cells (control
shRNA transfected embryos in A, H, I; IKBKAP shRNA in B–G) are EGFP+; right side of spinal cord is transfected in all embryos (asterisk). (A) control
shRNA transfected spinal cord develops normally in contrast to (B–D) IKBKAP shRNA transfected spinal cords in which cells at the ventricular zone
(VZ) often evaginate into the neural tube lumen rather than migrate laterally away from the VZ as in (A). IKBKAP shRNA-transfected evaginated cells
typically express neural markers such as Ben (C: box in B contains the Ben+ evaginated neurons in the VZ that are EGFP+ and magnified in C) and
Islet1/2 (D). Spinal interneuron populations are reduced in IKBKAP shRNA-transfected spinal cords including Engrailed+ cells (E) and the dorsal
population of Islet1+ cells – compare the left, non-transfected side of the spinal cords to the right, transfected sides (*asterisk) of the spinal cord. (F, I)
The ratio of islet 1+ dorsal interneurons on the transfected vs. non-transfected sides of the spinal cords was determined in multiple sections from 2
control shRNA transfected embryos (n=263 Islet+ cells for the control shRNA transfected side vs. n=252 Islet+ cells for the non-transfected side) and
in 4 IKBKAP shRNA transfected embryos (n=356 Islet+ cells for the transfected side of the IKBKAP shRNA spinal cord vs. n=658 Islet+ cells for the
non-transfected sides of the IKBKAP shRNA transfected embryos); p=0.006. (G, H) IKBKAP shRNA transfected motor axons branch abnormally (arrow
in G) as they exit the neural tube in the ventral root (compare H to I).; vertical line indicates spinal cord midline.
doi:10.1371/journal.pone.0032050.g005
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required for normal cytokinesis [47].
Our data suggest that IKAP/Elp1 participates in the organi-
zation or remodeling of the cytoskeleton during cytokinesis and in
branching from somata and axons. ShRNA knock-down of
IKBKAP mRNA in fibroblasts also induced an increase in
branching from cell bodies [13]. Since DRG neurons do not
normally extend dendrites, perhaps a normal function for IKAP/
Elp1 is to suppress branching in the PNS.
RNAi for IKAP in neuroblastoma cells and in fibroblasts caused
thedisorganizationofmicrotubules[13]. IKAP has also been shown
to bind to Filamin A, a protein that organizes the actin cytoskeleton
and interacts with cell adhesion pathways [12]. Interestingly, X-
LinkedPeriventricular Heterotopia is dueto mutationsin FilaminA
and is marked by an aggregation of neurons along the surface of the
ventricular zone. In our IKBKAP shRNA treated spinal cords, we
saw an aberrant evagination of cells into the lumen of the neural
tube which went on to express neuronal markers – an observation
also seen in embryos in which the neural tubes overexpress
cadherins [48–50]. IKAP/Elp1 is expressed in the ventricular zone
both in the brain[16] and in the spinalcord. Thusthe integrationof
signaling between IKAP, filamin A and cadherins may be essential
for orchestrating the reorganization of cytoskeleton during the
transition from cell cycle withdrawal to neuronal differentiation in
the CNS ventricular zone.
There has been a recent surge in interest in interactions between
IKAP/Elp1 and Elp3 with evidence that Elp3 mediates histone
H3 acetylation, and most recently, acetylation of a-tubulin
[16,51]. Acetylation of microtubules leads to stabilization and
recruitment of motor proteins that enable transport of proteins
and other cellular components [52]. Work in c.elegans showed
that decreasing Elp1 reduced the velocity of dense core vesicle
movement along axons by regulating microtubule acetylation [14].
In our study and also in [13] we did not find any reductions in
tubulin acetylation in the PNS [data not shown], which perhaps
points to differences in the function of IKAP/Elp1 in the PNS vs.
CNS, and/or to differences in Elp1 and Elp3 interactions in the
PNS vs. the CNS.
This study is the first to directly address whether FD results from
a problem in cell motility, a hypothesis which is currently popular
[e.g. 11]. Our data do not support a role for IKAP/Elp1 in the
Figure 6. IKAP regulates neuronal differentiation in the DRG.
Reduction in IKAP leads to increased numbers of neurons in the
immature DRG (A–C). Embryos at St. 12 were transfected with either
control shRNAs or IKBKAP shRNAs and analyzed at St 24/25. Embryos
were sectioned, and immunolabled with the neuronal markers Tuj-1 or
Ben and the percentage of GFP+ neurons determined. Significantly
more IKBKAP shRNA transfected DRG precursor cells differentiated into
neurons (arrows in B; IKBKAP shRNA 7.4; n=3 embryos; p=0.002;
IKBKAP shRNA 1.6 & 4.5, n=3 embryos; p=0.001) than Control shRNA
transfected DRG precursor cells (n=5 embryos). (D–H) IKBKAP shRNA-
transfected DRG precursor cells (n=3 embryos; 252 cleaved-Caspase 3+
cells counted) were also more likely to die by apoptosis (compare D & E
to F & G) than control shRNA-electroporated cells (n=3 embryos; 117
cleaved caspase-3+ cells counted). (H) The number of cleaved Caspase
3+ cells was quantified in DRG on both the transfected side of the
embryo and the non-transfected side of the embryo and a ratio
determined. Significantly more cleaved-Caspase 3+ cells were present in
the transfected DRG of IKBKAP shRNA transfected embryos than in the
transfected DRG in embryos transfected with control shRNAs; p=0.006.
(I–N). Over-expression of the c-terminus of IKAP prevents neural crest
cells from coalescing with the DRG (I, K, L; p=0.004) but the few that do
join, tend not to differentiate into neurons (p=0.007; J, M, N). Embryos
were transfected with either a construct driving expression of the c-
terminus of chicken IKAP with a His tag (CT-IKAP-His; L,N) or a control,
His-tagged construct (K, M) and analyzed at St. 21. The location and
neuronal identity of transfected cells was determined in 3 embryos for
each treatment; Control His-plasmid: n=343 transfected cells counted;
CT-IKAP-His: n=278 transfected cells counted. Statistical analysis by
Student t-test.
doi:10.1371/journal.pone.0032050.g006
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PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e32050motility and migration of neural crest cells, a result not surprising
given that we show here that IKAP only becomes detectable as
neurons begin to differentiate in the DRG. Our data suggest that
IKAP coordinates the intracellular machinery required for the
transition from neural precursors to neurons and in the
differentiation and survival of neurons in the PNS. Further
elucidation of the molecular interactions and intracellular
pathways in which IKAP participates will be required to fully
understand the cellular mechanisms that result in FD.
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